AstraZeneca – Trial Data for Gastric and Gastroesophageal Junction Cancers
Shubh Goel, VP, Head of Immuno-Oncology and GI Tumors Franchise at AstraZeneca discusses data presented at the European Society for Medical Oncology (ES...
42 articles
Shubh Goel, VP, Head of Immuno-Oncology and GI Tumors Franchise at AstraZeneca discusses data presented at the European Society for Medical Oncology (ES...
Roy Herbst, MD, PhD, from the Yale School of Medicine and primary investigatory of the ADAURA Phase III trial discusses the positive results that show T...
Anas Younes, Senior Vice President, Head of Haematology R&D, at AstraZeneca, discusses building a broad portfolio to target different hematological canc...
Levy, GSK Global Medical Expert, Immunology & Specialty Medicine discusses the results from a global survey of rheumatologists, nephrologists and ...
Eugene Chan, MD, MPH, is the chairman and co-founder of Abpro, a company working to advance monoclonal antibodies to be used to treat Covid-19.
Shankar Musunuri, Chairman, Co-founder, and CEO of Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel g...
Rajarshi Banerjee, Ph.D., Co-Founder and CEO of Perspectum, a digital medical technology and diagnostics company, talks about why A.I.
Brad McElya, PharmD, Walgreens Director of Specialty Health Solutions discusses the National HIV Testing Day this past June 27 and how Walgreens worked ...
Michael Kelly, Clinical Fellow in Pediatrics at Massachusetts General Hospital shares more about his research, "Burnout, Disparities, and Outcomes of th...
Angela Mickalide, PhD, MCHES, Vice President, Programs & Education, American College of Preventive Medicine discusses her involvement in the Vaccine Con...